212 related articles for article (PubMed ID: 26147434)
1. Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance.
Kohlscheen S; Wintterle S; Schwarzer A; Kamp C; Brugman MH; Breuer DC; Büsche G; Baum C; Modlich U
PLoS One; 2015; 10(7):e0131866. PubMed ID: 26147434
[TBL] [Abstract][Full Text] [Related]
2. Endothelial protein C receptor supports hematopoietic stem cell engraftment and expansion in Mpl-deficient mice.
Kohlscheen S; Schenk F; Rommel MGE; Cullmann K; Modlich U
Blood; 2019 Mar; 133(13):1465-1478. PubMed ID: 30683655
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche.
Yoshihara H; Arai F; Hosokawa K; Hagiwara T; Takubo K; Nakamura Y; Gomei Y; Iwasaki H; Matsuoka S; Miyamoto K; Miyazaki H; Takahashi T; Suda T
Cell Stem Cell; 2007 Dec; 1(6):685-97. PubMed ID: 18371409
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral gene transfer regenerates hematopoietic stem cells in a mouse model for Mpl-deficient aplastic anemia.
Heckl D; Wicke DC; Brugman MH; Meyer J; Schambach A; Büsche G; Ballmaier M; Baum C; Modlich U
Blood; 2011 Apr; 117(14):3737-47. PubMed ID: 21289307
[TBL] [Abstract][Full Text] [Related]
5. Ott1 (Rbm15) regulates thrombopoietin response in hematopoietic stem cells through alternative splicing of c-Mpl.
Xiao N; Laha S; Das SP; Morlock K; Jesneck JL; Raffel GD
Blood; 2015 Feb; 125(6):941-8. PubMed ID: 25468569
[TBL] [Abstract][Full Text] [Related]
6. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells.
Matsuoka Y; Takahashi M; Sumide K; Kawamura H; Nakatsuka R; Fujioka T; Sonoda Y
Cell Transplant; 2017 Jun; 26(6):1043-1058. PubMed ID: 27938494
[TBL] [Abstract][Full Text] [Related]
7. Niche regulation of hematopoietic stem cells in the endosteum.
Arai F; Yoshihara H; Hosokawa K; Nakamura Y; Gomei Y; Iwasaki H; Suda T
Ann N Y Acad Sci; 2009 Sep; 1176():36-46. PubMed ID: 19796231
[TBL] [Abstract][Full Text] [Related]
8. CLEC-2 in megakaryocytes is critical for maintenance of hematopoietic stem cells in the bone marrow.
Nakamura-Ishizu A; Takubo K; Kobayashi H; Suzuki-Inoue K; Suda T
J Exp Med; 2015 Nov; 212(12):2133-46. PubMed ID: 26552707
[TBL] [Abstract][Full Text] [Related]
9. The thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis.
Chou FS; Mulloy JC
J Cell Biochem; 2011 Jun; 112(6):1491-8. PubMed ID: 21360575
[TBL] [Abstract][Full Text] [Related]
10. Signals emanating from the membrane proximal region of the thrombopoietin receptor (mpl) support hematopoietic stem cell self-renewal.
Tong W; Ibarra YM; Lodish HF
Exp Hematol; 2007 Sep; 35(9):1447-55. PubMed ID: 17637498
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted roles of thrombopoietin in hematopoietic stem cell regulation.
Nakamura-Ishizu A; Suda T
Ann N Y Acad Sci; 2020 Apr; 1466(1):51-58. PubMed ID: 31292976
[TBL] [Abstract][Full Text] [Related]
12. Signaling properties of murine MPL and MPL mutants after stimulation with thrombopoietin and romiplostim.
Rommel MGE; Hoerster K; Milde C; Schenk F; Roser L; Kohlscheen S; Heinz N; Modlich U
Exp Hematol; 2020 May; 85():33-46.e6. PubMed ID: 32417303
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of thrombopoietin in bone marrow failure].
Shiozaki H; Nakamura-Ishizu A; Suda T
Rinsho Ketsueki; 2020; 61(10):1449-1458. PubMed ID: 33162439
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness.
Bradley HL; Couldrey C; Bunting KD
Blood; 2004 Apr; 103(8):2965-72. PubMed ID: 15070672
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the differential impact of thrombopoietin/MPL signaling on hematopoietic stem/progenitor cell function in bone marrow and spleen.
Lee S; Zhan H
Stem Cell Reports; 2024 Feb; 19(2):211-223. PubMed ID: 38215758
[TBL] [Abstract][Full Text] [Related]
16. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells.
Qian H; Buza-Vidas N; Hyland CD; Jensen CT; Antonchuk J; Månsson R; Thoren LA; Ekblom M; Alexander WS; Jacobsen SE
Cell Stem Cell; 2007 Dec; 1(6):671-84. PubMed ID: 18371408
[TBL] [Abstract][Full Text] [Related]
17. The thrombopoietin receptor P106L mutation functionally separates receptor signaling activity from thrombopoietin homeostasis.
Stockklausner C; Klotter AC; Dickemann N; Kuhlee IN; Duffert CM; Kerber C; Gehring NH; Kulozik AE
Blood; 2015 Feb; 125(7):1159-69. PubMed ID: 25538044
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.
Nishikawa S; Arai S; Masamoto Y; Kagoya Y; Toya T; Watanabe-Okochi N; Kurokawa M
Blood; 2014 Dec; 124(24):3587-96. PubMed ID: 25298035
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin from hepatocytes promotes hematopoietic stem cell regeneration after myeloablation.
Gao L; Decker M; Chen H; Ding L
Elife; 2021 Aug; 10():. PubMed ID: 34463253
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocytes are essential for HSC quiescence through the production of thrombopoietin.
Nakamura-Ishizu A; Takubo K; Fujioka M; Suda T
Biochem Biophys Res Commun; 2014 Nov; 454(2):353-7. PubMed ID: 25451253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]